Revista médica de Chile
-
Revista médica de Chile · Mar 2022
[Obstacles and enablers for the use of barrier methods to avoid HIV/AIDS transmission].
There is an increase in HIV/AIDS transmission rates world-wide Aim: To explore obstacles and facilitators in the use of barrier methods for the prevention of HIV/AIDS among Chilean young people between 20 and 29 years of age. ⋯ There are culturally embedded beliefs among young people, such as, a perception of invulnerability caused by not being part of risk groups, among others, that affect self-care.
-
Revista médica de Chile · Mar 2022
[How do patients on dialysis experience their disease? A qualitative approach].
End-stage chronic kidney disease is a severe public health problem due to the poor quality of life of patients on dialysis and the costs associated with renal replacement treatment. ⋯ Health care of people on dialysis should take into consideration the experience of kidney disease from the perspective of the patient, including his beliefs and feelings and involving the family, community, and the state.
-
Revista médica de Chile · Mar 2022
[Perception of the educational environment in residents of medical specialties in Chilean universities].
The Learning Environment (LE) influences the performance of students, learning, social life, mental health, and the future of work. ⋯ LE among medical specialties had more positive than negative features, but with areas that should be improved.
-
Revista médica de Chile · Mar 2022
[Evaluation of a clinical orientation Call Center during the first months of the COVID-19 pandemic].
During sanitary emergencies such as the recent pandemic, health services can collapse. In these cases, remote orientation services such as call centers may help to debottleneck these services. ⋯ The call center had a high level of resolution, favoring remote consultation and reducing face-to-face care, improving users'accessibility.
-
Revista médica de Chile · Mar 2022
[The impact of novel drugs on the survival of patients with multiple myeloma in two chilean centers].
The incorporation of novel drugs, such as proteasome inhibitors and immunomodulators, improved considerably the survival of patients with multiple myeloma. ⋯ The use of novel drugs, especially bortezomib, and autologous stem-cell transplantation significantly improved the survival of multiple myeloma patients treated in national hospitals. It is necessary to include them as a first line treatment.